Because we’re making headlines

We do it by making a difference in the lives of our patients. Stay current with the latest news, information (including our recent and archived press releases) and social media.

Please visit our investor site for a complete list of press releases.

Filter

Press Release

Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers

June 27, 2024

Read More at Our Investor Site

Social Media

View all

LinkedIn

NEWS: Lantheus today announced that it welcomes the Centers for Medicare & Medicaid Services’ (CMS) Proposed Medicare Hospital Outpatient Prospective Payment System Rule for calendar year 2025 to improve access to specialized diagnostic radiopharmaceuticals for Medicare beneficiaries. These updates would ensure more patients living with prostatecancer and other diseases are able to receive the care they need. Read the full release here: https://bit.ly/45ZuokI LantheusRadiopharma LeadingRadiopharma FindFightFollow

July 10, 2024

Read on LinkedIn

LinkedIn

At Lantheus, social wellness is a core component of our Value to Let People Be Their Best. We’re celebrating SocialWellnessMonth by taking care of our social, physical and mental wellbeing through quality time and connections. This month and beyond, TeamLantheus creates a positive environment for our community so we can continue to FindFightFollow for patients! Join us this month and celebrate your socialwellness!

July 10, 2024

Read on LinkedIn

Receive Email Alerts

Media Contact

Melissa Downs

Senior Director, Corporate Communications
646-975-2533

media@lantheus.com

Investors

Mark Kinarney

Vice President, Investor Relations
978-671-8842

ir@lantheus.com